scholarly article | Q13442814 |
P50 | author | Eliezer Masliah | Q28324209 |
P2093 | author name string | Mallory M | |
Fox L | |||
Alford M | |||
Achim C | |||
P433 | issue | 4 | |
P921 | main subject | neurodegeneration | Q1755122 |
P304 | page(s) | 360-368 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
P1476 | title | Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis | |
P478 | volume | 56 |
Q42743771 | 4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis |
Q46925688 | Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons |
Q45955687 | CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease. |
Q42127774 | Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. |
Q35125862 | Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND) |
Q82676429 | Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain |
Q34306673 | DNA immunization and central nervous system viral infection |
Q36302081 | Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin |
Q36162221 | Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults |
Q45033937 | HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations. |
Q24628614 | Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons |
Q35020086 | Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity |
Q36511938 | Immune modulation by estrogens: role in CNS HIV-1 infection |
Q37351271 | Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors |
Q36984709 | Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation |
Q37340889 | Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy |
Q37264028 | Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. |
Q38101560 | Neuronal toxicity in HIV CNS disease |
Q36003825 | Neuroprotective strategies for HIV-1 associated dementia. |
Q36845234 | Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection |
Q33870898 | Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport |
Q34802758 | Neurotrophins modulate the expression of chemokine receptors in the brain |
Q61800083 | Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis |
Q27025573 | Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders |
Q52691950 | Somatostatin Maintains Permeability and Integrity of Blood-Brain Barrier in β-Amyloid Induced Toxicity. |
Q34017941 | Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice |
Q37003023 | Substance abuse, HIV-1 and hepatitis |
Q40486706 | The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study |
Q44532509 | The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms. |
Q36302049 | The shifting patterns of HIV encephalitis neuropathology |
Q34776120 | Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders |
Q36188164 | When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration? |
Search more.